ezogabine has been researched along with thallium in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (thallium) | Trials (thallium) | Recent Studies (post-2010) (thallium) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 4,958 | 159 | 531 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, DJ; Baranowski, JL; DeGoey, DA; Gopalakrishnan, M; Honore, P; Patel, JR; Peddi, S; Perez-Medrano, A; Scanio, M; Surowy, CS; Thimmapaya, R; Wang, Z; Yao, BB; Zhang, D; Zhang, XF | 1 |
1 other study(ies) available for ezogabine and thallium
| Article | Year |
|---|---|
KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
Topics: Carbamates; HEK293 Cells; Humans; Ion Channel Gating; KCNQ Potassium Channels; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Mutation; Phenylenediamines; Thallium | 2011 |